2021
DOI: 10.1016/j.jep.2021.114375
|View full text |Cite
|
Sign up to set email alerts
|

Caesalpinia bonduc (L.) Roxb. as a promising source of pharmacological compounds to treat Poly Cystic Ovary Syndrome (PCOS): A review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 26 publications
(17 citation statements)
references
References 30 publications
0
15
0
Order By: Relevance
“…Numerous research studies have been conducted to demonstrate its anti-diabetic, anti-cancer, anti-inflammatory, and anti-pyretic properties with recent studies concentrating on its antiestrogenic and anti-androgenic properties. 51 Gupta et al 52 reported that C. bonduc seeds demonstrated a significant anti-cancer property when studied using the Ehrlich ascites carcinoma model in Swiss albino mice. In this study, ethanol seed extract treated mice showed a substantial decrease in tumor size and a higher life span than the non-treated control tumor-induced mice.…”
Section: Discussionmentioning
confidence: 99%
“…Numerous research studies have been conducted to demonstrate its anti-diabetic, anti-cancer, anti-inflammatory, and anti-pyretic properties with recent studies concentrating on its antiestrogenic and anti-androgenic properties. 51 Gupta et al 52 reported that C. bonduc seeds demonstrated a significant anti-cancer property when studied using the Ehrlich ascites carcinoma model in Swiss albino mice. In this study, ethanol seed extract treated mice showed a substantial decrease in tumor size and a higher life span than the non-treated control tumor-induced mice.…”
Section: Discussionmentioning
confidence: 99%
“…, 2011 ). Recently, the studies on seed extraction showed that C. bonduc contains antioxidant properties that can be used to prevent the lipid peroxidation of the cell membrane and the management of polycystic ovary syndrome ( Suhani et al., 2019 ; Meera et al., 2020 ; Sumithra et al., 2021 ; Kandasamy and Balasundaram, 2021 ).…”
Section: Introductionmentioning
confidence: 99%
“…For instance, phanginin D triggers apoptosis by activating caspase-3, phanginin R induces apoptosis by enhancing the (PARP) activity, and procaspase-3 cleavage also increases the ratio of Bax/Bcl-2 and the p53 protein expression [ 23 , 24 ]. Additionally, caesalpin G induces apoptosis via another apoptotic mechanism, promoting ER stress and suppressing the Wnt/β-catenin signaling pathway [ 3 , 25 , 26 ].…”
Section: Resultsmentioning
confidence: 99%